Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 1:12 pm Sale | 2026-03-31 | 13G | ENGENE HLDGS INC ENGN | Cormorant Asset Management, LP | 0 0.000% | -4,000,000 (Position Closed) | Filing History |
| 2026-05-14 10:30 am Purchase | 2026-05-12 | 13G | ENGENE HLDGS INC ENGN | BML Investment Partners, L.P. | 6,669,908 9.950% | 1,444,908 (+27.65%) | Filing History |
| 2026-05-13 9:23 pm Purchase | 2026-05-08 | 13G | ENGENE HLDGS INC ENGN | BML Investment Partners, L.P. | 5,225,000 7.800% | 5,225,000 (New Position) | Filing History |
| 2026-05-05 10:59 am Purchase | 2026-03-31 | 13G | ENGENE THERAPEUTICS INC ENGN | Invus Public Equities, L.P. | 5,253,159 7.800% | 1,008,600 (+23.76%) | Filing History |
| 2026-02-17 6:09 pm Sale | 2025-12-31 | 13G | ENGENE HLDGS INC ENGN | Venrock Healthcare Capital Partners III, L.P. | 4,771,414 7.100% | -275,000 (-5.45%) | Filing History |
| 2026-02-17 3:00 pm Purchase | 2025-12-31 | 13G | ENGENE HLDGS INC ENGN | Cormorant Asset Management, LP | 4,000,000 5.970% | 4,000,000 (New Position) | Filing History |
| 2026-02-17 12:46 pm Sale | 2025-12-31 | 13G | ENGENE HLDGS INC ENGN | Kynam Capital Management, LP | 1,492,898 2.230% | -3,501,192 (-70.11%) | Filing History |
| 2026-01-27 2:18 pm Purchase | 2026-01-21 | 13G | ENGENE HLDGS INC ENGN | Invus Public Equities, L.P. | 4,244,559 6.300% | 4,244,559 (New Position) | Filing History |
| 2025-11-18 4:01 pm Purchase | 2025-11-11 | 13G | ENGENE HLDGS INC ENGN | Deep Track Capital, LP | 4,317,332 6.690% | 2,077,979 (+92.79%) | Filing History |
| 2025-11-18 4:00 pm Purchase | 2025-11-11 | 13G | ENGENE HLDGS INC ENGN | Perceptive Advisors LLC | 6,770,605 9.990% | 6,770,605 (New Position) | Filing History |
| 2025-11-14 08:12 am Sale | 2025-09-30 | 13G | ENGENE HLDGS INC ENGN | Deep Track Capital, LP | 2,239,353 4.370% | -2,318,222 (-50.87%) | Filing History |
| 2025-02-14 6:15 pm Purchase | 2024-12-31 | 13G | ENGENE HLDGS INC ENGN | Venrock Healthcare Capital Partners III, L.P. | 5,046,414 9.900% | 1,480,573 (+41.52%) | Filing History |
| 2025-02-14 5:16 pm Purchase | 2024-12-31 | 13G | ENGENE HLDGS INC ENGN | Kynam Capital Management, LP | 4,994,090 9.800% | 4,994,090 (New Position) | Filing History |
| 2025-02-14 2:25 pm Sale | 2024-09-30 | 13G | ENGENE HLDGS INC ENGN | Foresite Capital Fund VI LP | 0 0.000% | -2,500,000 (Position Closed) | Filing History |
| 2025-02-14 08:46 am Purchase | 2024-12-31 | 13G | ENGENE HLDGS INC ENGN | Deep Track Capital, LP | 4,557,575 8.940% | 2,307,575 (+102.56%) | Filing History |
| 2025-02-12 09:35 am Sale | 2024-12-31 | 13G | ENGENE HLDGS INC ENGN | Adage Capital Management, L.P. | 1,528,768 3.000% | -801,000 (-34.38%) | Filing History |
| 2025-01-29 5:12 pm Sale | 2025-01-27 | 13G | ENGENE HLDGS INC ENGN | BIOTECHNOLOGY VALUE FUND L P | 945,402 1.800% | -2,106,037 (-69.02%) | Filing History |
| 2025-01-29 5:09 pm Sale | 2024-12-31 | 13G | ENGENE HLDGS INC ENGN | BIOTECHNOLOGY VALUE FUND L P | 3,051,439 5.900% | -145,000 (-4.54%) | Filing History |
| 2024-11-14 5:48 pm Purchase | 2024-09-30 | 13G | ENGENE HLDGS INC ENGN | Venrock Healthcare Capital Partners III, L.P. | 3,565,841 8.100% | 1,000,000 (+38.97%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | ENGENE HLDGS INC ENGN | Blue Owl Capital Holdings LP | 3,095,069 7.000% | 1,860,309 (+150.66%) | Filing History |